181 related articles for article (PubMed ID: 7959284)
1. Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Karck U; Kommoss F; du Bois A; Pfleiderer A
Gynecol Oncol; 1994 Nov; 55(2):198-205. PubMed ID: 7959284
[TBL] [Abstract][Full Text] [Related]
2. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
[TBL] [Abstract][Full Text] [Related]
5. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor.
Vandamme B; Lissens W; Amfo K; De Sutter P; Bourgain C; Vamos E; De Grève J
Cancer Res; 1992 Dec; 52(23):6646-52. PubMed ID: 1423308
[TBL] [Abstract][Full Text] [Related]
6. Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer?
Panani AD
Cancer Lett; 2007 Dec; 258(2):262-7. PubMed ID: 17945413
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of heterozygosity at 11p loci in testicular cancer.
Smith RC; Rukstalis DB
J Urol; 1995 May; 153(5):1684-7. PubMed ID: 7715010
[TBL] [Abstract][Full Text] [Related]
8. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
[TBL] [Abstract][Full Text] [Related]
9. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
Amfo K; Neyns B; Teugels E; Lissens W; Bourgain C; De Sutter P; Vandamme B; Vamos E; De Grève J
Oncogene; 1995 Jul; 11(2):351-8. PubMed ID: 7624149
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas.
Ehlen T; Dubeau L
Oncogene; 1990 Feb; 5(2):219-23. PubMed ID: 2320374
[TBL] [Abstract][Full Text] [Related]
11. Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.
Kiechle-Schwarz M; Bauknecht T; Wienker T; Walz L; Pfleiderer A
Cancer; 1993 Oct; 72(8):2423-32. PubMed ID: 8402459
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in human ovarian cancer on chromosome 19q.
Bicher A; Ault K; Kimmelman A; Gershenson D; Reed E; Liang B
Gynecol Oncol; 1997 Jul; 66(1):36-40. PubMed ID: 9234918
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.
Srivatsan ES; Murali V; Seeger RC
Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
17. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
18. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic studies of prostatic cancer.
Lundgren R
Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
[TBL] [Abstract][Full Text] [Related]
20. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map.
Micci F; Weimer J; Haugom L; Skotheim RI; Grunewald R; Abeler VM; Silins I; Lothe RA; Trope CG; Arnold N; Heim S
Genes Chromosomes Cancer; 2009 Feb; 48(2):184-93. PubMed ID: 18973136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
